Solarea Bio Company
.jpg)
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Connections from
Founded Date:
2017-01-01
Last Funding Type:
Series A
Headquarters:
Cambridge, Massachusetts, United States
Industry:
General Healthcare
Last Funding Date:
2020-10-19
Funding Status:
Early Stage Venture
Total Funding:
$11 200 000